Cytokinetics (CYTK) Misses Q3 EPS by 59c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $76.84 -0.44%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.35), $0.59 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
